PharVision Advisers »

T. Rowe Price shares owned by PharVision Advisers

Quarter-by-quarter ownership of T. Rowe Price (TROW) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in T. Rowe Price

Tip: Access up to 7 years of quarterly data

All positions including T. Rowe Price held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in T. Rowe Price by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $386k 3.8k 102.64

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding T. Rowe Price

Vanguard Group
BlackRock
State Street Corporation
Charles Schwab Investment Management
Geode Capital Management
Fayez Sarofim & Co
Invesco
Morgan Stanley
UBS Group
Royal Bank of Canada
Provident Trust
Northern Trust
Ubs Global Asset Management Americas
Legal & General Group
Dimensional Fund Advisors

View all funds holding T. Rowe Price